Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer-Reference-Cited by-同舟云学术

Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer

Published:2017-06-23 Issue:7 Volume:108 Page:1452-1457
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Obara Wataru¹^ORCID,Sato Fuminori²,Takeda Kazuyoshi³⁴,Kato Renpei¹,Kato Yoichiro¹,Kanehira Mitsugu¹,Takata Ryo¹,Mimata Hiromitsu²,Sugai Tamotsu⁵,Nakamura Yusuke⁶,Fujioka Tomoaki¹

Affiliation:

1. Department of Urology; Iwate Medical University School of Medicine; Morioka Japan

2. Department of Urology; Oita University Faculty of Medicine; Oita Japan

3. Division of Cell Biology; Biomedical Research Center; Graduated School of Medicine; Juntendo University; Tokyo Japan

4. Department of Biofunctional Micribiota; Graduated School of Medicine; Juntendo University; Tokyo Japan

5. Department of Molecular Diagnostic Pathology; Iwate Medical University School of Medicine; Morioka Japan

6. Department of Medicine and Surgery; University of Chicago; Chicago Illinois USA

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13278/fullpdf

Reference28 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Abiraterone and increased survival in metastatic prostate cancer;Bono;N Engl J Med,2011

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;Bono;Lancet,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking Immunity: Innovative prostate cancer vaccine strategies;International Immunopharmacology;2024-12

2. Role of cell division cycle-associated proteins in regulating cell cycle and promoting tumor progression;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Targeting NUF2 suppresses gastric cancer progression through G2/M phase arrest and apoptosis induction;Chinese Medical Journal;2024-08-28

4. A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma;Esophagus;2024-07-11

5. CDCA gene family promotes progression and prognosis in lung adenocarcinoma;Medicine;2024-06-14